Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000952817 | SCV001099348 | likely benign | not provided | 2018-06-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004029843 | SCV002611919 | likely benign | not specified | 2022-03-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000952817 | SCV004125787 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | OBSCN: BP4, BP7 |
Prevention |
RCV003960643 | SCV004772237 | likely benign | OBSCN-related disorder | 2019-12-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |